Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers.
Saved in:
| Title: | Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers. |
|---|---|
| Authors: | Scurr, Martin J.1,2 (AUTHOR), Zelek, Wioleta M.3,4 (AUTHOR), Lippiatt, George2 (AUTHOR), Somerville, Michelle1 (AUTHOR), Burnell, Stephanie E. A.1 (AUTHOR), Capitani, Lorenzo1 (AUTHOR), Davies, Kate5 (AUTHOR), Lawton, Helen5 (AUTHOR), Tozer, Thomas6 (AUTHOR), Rees, Tara6 (AUTHOR), Roberts, Kerry6 (AUTHOR), Evans, Mererid7 (AUTHOR), Jackson, Amanda7 (AUTHOR), Young, Charlotte7 (AUTHOR), Fairclough, Lucy8 (AUTHOR), Tighe, Paddy8 (AUTHOR), Wills, Mark9 (AUTHOR), Westwell, Andrew D.10 (AUTHOR), Morgan, B. Paul3,4 (AUTHOR), Gallimore, Awen1,3 (AUTHOR) godkinaj@cardiff.ac.uk |
| Source: | Immunology. Feb2022, Vol. 165 Issue 2, p250-259. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00192805 |
|---|---|
| DOI: | 10.1111/imm.13433 |
